Skip to main content

previous disabled Page of 6
and
  1. Article

    Open Access

    Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

    Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons in Leukemia (2024)

  2. Article

    Open Access

    Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation

    DEAD box helicase 41 (DDX41) mutations are the most prevalent predisposition to familial myelodysplastic syndrome (MDS). However, the precise roles of these variants in the pathogenesis of MDS have yet to be e...

    Won Chan Hwang, Kibeom Park, Silvia Park, Na Young Cheon, Ja Yil Lee in Leukemia (2024)

  3. No Access

    Article

    Trigeminal neuralgia

    Trigeminal neuralgia (TN) is a facial pain disorder characterized by intense and paroxysmal pain that profoundly affects quality of life and presents complex challenges in diagnosis and treatment. TN can be ca...

    Sait Ashina, Carrie E. Robertson, Anan Srikiatkhachorn in Nature Reviews Disease Primers (2024)

  4. Article

    Open Access

    Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion

    Patient-derived organoids (PDOs) are valuable in predicting response to cancer therapy. PDOs are ideal models for precision oncologists. However, their practical application in guiding timely clinical decision...

    Sang-Hyun Lee, Kyuhwan Kim, Eunyoung Lee, Kyungmin Lee in npj Precision Oncology (2024)

  5. No Access

    Article

    STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response

    Hematopoietic stem and progenitor cells (HSPCs) maintain blood-forming and immune activity, yet intrinsic regulators of HSPCs remain elusive. STAT3 function in HSPCs has been difficult to dissect as Stat3-deficie...

    Bhakti Patel, Yifan Zhou, Rachel L. Babcock, Feiyang Ma, M. Anna Zal in Leukemia (2024)

  6. Article

    Open Access

    Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations

    Triple-negative breast cancer (TNBC) patients are more likely to have BRCA1/2 mutations, with a prevalence rate of about 10–20%. Although several studies have analyzed the oncologic outcomes between BRCA1/2 carri...

    Woong Ki Park, Soo Yeon Chung, You ** Jung, Changhee Ha in npj Precision Oncology (2024)

  7. No Access

    Article

    Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms

    Tatiana Raskovalova, Marie-Christine Jacob, Sophie Park in Leukemia (2024)

  8. No Access

    Article

    Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

    Marie Sébert, Lucie Freiman, Cendrine Chaffaut, Agnès Guerci, Pierre Peterlin in Leukemia (2024)

  9. Article

    Open Access

    ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma

    Glioblastoma (GBM), the most lethal primary brain cancer, exhibits intratumoral heterogeneity and molecular plasticity, posing challenges for effective treatment. Despite this, the regulatory mechanisms underl...

    Yona Kim, Ji Hyeon You, Yeonjoo Ryu, Gyuri Park, Urim Lee in npj Precision Oncology (2024)

  10. Article

    Open Access

    Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer

    Genetic alternation of REarranged during Transfection (RET) that leads to constitutive RET activation is a crucial etiological factor for thyroid cancer. RET is known to regulate mitochondrial processes, although...

    Wen**g Chen, Sophie Dream, Pui-Yin Leung, Pui-Kei Wu in npj Precision Oncology (2024)

  11. No Access

    Article

    Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS—a cohort analysis

    Kyoo-Hyung Lee, Sewon Lee, Young Hoon Park, Yeung-Chul Mun, Eun-Ji Choi in Leukemia (2024)

  12. Article

    Open Access

    Immunological subty** of salivary gland cancer identifies histological origin-specific tumor immune microenvironment

    Gene expression analysis enhances proper cancer subty**, a better understanding of the molecular characteristics of cancer, and strategies for precision medicine. However, salivary gland cancer (SGC) subtypi...

    Jiyun Hong, Eunwoo Choi, Dahee Kim, Mi-Kyoung Seo, Hyundeok Kang in npj Precision Oncology (2024)

  13. Article

    Open Access

    Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer

    Tumor-infiltrating lymphocytes (TIL) have been suggested as an important prognostic marker in colorectal cancer, but assessment usually requires additional tissue processing and interpretational efforts. The a...

    Yoojoo Lim, Songji Choi, Hyeon Jeong Oh, Chanyoung Kim in npj Precision Oncology (2023)

  14. Article

    Open Access

    Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases

    Melanoma brain metastases (MBM) are clinically challenging to treat and exhibit variable responses to immune checkpoint therapies. Prior research suggests that MBM exhibit poor tumor immune responses and are e...

    Gino K. In, Jennifer R. Ribeiro, Jun Yin, Joanne **u in npj Precision Oncology (2023)

  15. Article

    Open Access

    Perspectives on acute myeloid leukemia diagnosis: a comparative analysis of the latest World Health Organization and the International Consensus Classifications

    ** Jung, Daehun Kwag, Yonggoo Kim, Jong-Mi Lee, Ari Ahn, Hoon Seok Kim in Leukemia (2023)

  16. No Access

    Article

    Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia

    Vitamin C has been demonstrated to regulate hematopoietic stem cell frequencies and leukemogenesis by augmenting and restoring Ten-Eleven Translocation-2 (TET2) function, potentially acting as a promising adju...

    Jun Liu, Suji Min, Dongchan Kim, Jihyun Park, Eunchae Park, Shanshan Pei in Leukemia (2023)

  17. Article

    Open Access

    ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma

    Optimal first-line treatment that enables deeper and longer remission is crucially important for newly diagnosed multiple myeloma (NDMM). In this study, we developed the machine learning (ML) models predicting...

    Sung-Soo Park, Jong Cheol Lee, Ja Min Byun, Gyucheol Choi in npj Precision Oncology (2023)

  18. Article

    Open Access

    Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

    Poorly differentiated pancreatic neuroendocrine tumors (PDNEC), are a subtype of pancreatic cancer encompassing both small cell and large cell neuroendocrine carcinoma subtypes, and are characterized as distin...

    Fergus Keane, Raazi Bajwa, Pier Selenica, Wungki Park in npj Precision Oncology (2023)

  19. No Access

    Article

    The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial

    Clinical effect of donor-derived natural killer cell infusion (DNKI) after HLA-haploidentical hematopoietic cell transplantation (HCT) was evaluated in high-risk myeloid malignancy in phase 2, randomized trial...

    Kyoo-Hyung Lee, Suk Ran Yoon, Jeong-Ryeol Gong, Eun-Ji Choi, Hun Sik Kim in Leukemia (2023)

  20. Article

    Open Access

    Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus

    The biosynthesis of host lipids and/or lipid droplets (LDs) has been studied extensively as a putative therapeutic target in diverse viral infections. However, directly targeting the LD lipolytic catabolism in...

    Yeong-Bin Baek, Hyung-Jun Kwon, Muhammad Sharif in Signal Transduction and Targeted Therapy (2022)

previous disabled Page of 6